CTN Webinar: Relapse Prevention.
CTN Webinar: Relapse Prevention. – This 90-minute webinar, produced by the National Drug Abuse Treatment Clinical Trials Network (CTN) Clinical Coordinating Center for CTN members and the public, explores the issue of relapse among individuals with substance use disorders (SUD). Outcome studies, types and effects of lapse and relapse, and factors contributing to relapse are reviewed. A major emphasis of the webinar is on discussing specific clinical strategies to reduce relapse risk, with a focus on current empirical and clinical literature, including findings from quality improvement studies and clinical trials conducted in a drug treatment clinic. The target audience is CTN members and other researchers and clinicians interested in learning more about relapse prevention. Presented by Dennis Daley, PhD, LSW (Western Psychiatric Institute and Clinic, AT Node) and Dennis M. Donovan, PhD (Alcohol & Drug Abuse Institute, University of Washington, PN Node). For more resources related to this webinar, as well as other webinars in this series, visit: ctndisseminationlibrary.org
Perianal Dermatitis: Much More Than Just a Diaper Rash
Filed under: drug abuse treatment outcome study
A recent retrospective study of 81 children with SPD by Olson and Bruce3 reported a high rate of recurrence in SPD after treatment with either a penicillin drug (38%) or beta-lactamase resistant antibiotic (28%). … Although rarely discussed in …
Read more on Healio
Future Looks Promising for Mental Illness Prevention
Filed under: drug abuse treatment outcome study
A Dutch study found a 50 percent reduction in the incidence of major depression among mildly depressed primary care patients who received a stepped-care intervention, compared with the incidence among primary care patients who received treatment as …
Read more on Psychiatric News
Georgia Gov. Nathan Deal's 2013 State of the State Speech
Filed under: drug abuse treatment outcome study
These options range from substance abuse treatment to family counseling and provide judges with viable, alternative sentencing options. Just as with last year, we stand to … Since employment is a primary goal of education, I want to commend the …
Read more on Governing
Faruqi & Faruqi, LLP Encourages Investors Who Suffered 0000 In Losses …
Filed under: drug abuse treatment outcome study
The investigation focuses on whether the Company and its executives violated federal securities laws by misleading investors to believe that one of the drugs in Isis' product pipeline, Kynamro, would receive approval from the U.S. Food and Drug … On …
Read more on Sacramento Bee